P463
Allogeneic Stem Cell Transplant in Treating Patients With Metastatic Kidney CancerSAFIR02_Lung - Efficacy of Targeted Drugs Guided by Genomic Profils in Metastatic NSCLC PatientsSAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast CancerEarly Biomarkers of Tumor Response in High Dose Hypofractionated Radiotherapy Word Package 3 : Immune ResponseImmunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung CancerImmunotherapy With Neo-adjuvant Chemotherapy for OVarian CancerPhase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular CarcinomaA Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast CancerAdjuvant Palbociclib in Elderly Patients With Breast CancerEvaluation of the Added Value of a Large Molecular Profiling Panel Versus a Limited Molecular Profiling Panel in Advanced Solid Tumors.Axillary Sentinel Lymph Node Detection in Breast Cancers > 2 cmA Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By SurgeryRadiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate CancerImatinib in Adult Patients With Metastatic Ocular MelanomaRadiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical CancerMetronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative CancerSentinel Lymph Node Technique in Multifocal Breast CancerEndoTAG-1 in Triple Receptor Negative Breast Cancer PatientsPhase III Study (Tarceva®) vs Chemotherapy to Treat Advanced Non-Small Cell Lung Cancer (NSCLC) in Patients With Mutations in the TK Domain of EGFRProspective Multicentric Randomized Study of Glivec® in Advanced GIST Expressing C-kit: Interruption After 5 Years vs MaintenancePharmacokinetic Study of Doxorubicin in Children With CancerDNA Repair Inhibitor & Irradiation on MelanomaFrench Biological Observatory on Lung Cancer in Never SmokersPregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014Study of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast CancerValidity of HER2-amplified Circulating Tumor Cells to Select Metastatic Breast Cancer Considered HER2-negative for Trastuzumab-emtansine (T-DM1) Treatment.Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast CancerObservation Versus Post-surgery Radiotherapy After Complete Exeresis in Soft Tissues Members SarcomaStereotactic Body Radio Therapy (SBRT) for Early-stage Non Small Cell Lung Cancer (NSCLC)Radiation Therapy + Combination Chemotherapy as 1st-Line Therapy for Patients With Inoperable Esophageal CancerTrial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination PathwayEffects of a Neuroscience-based Technique on Post-traumatic Stress Disorder Symptoms, Inflammation, and Survival in Cancer Patients Announced of a Palliative Disease Progression and Their PartnersRecurrent Ovarian CarcinoSarcoma Anti-pd-1 NiraparibTislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction CarcinomaMEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast CancerUTOLA: UTerin OLAparibRadiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCombination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Pancreatic CancerTriptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
P6153
Imatinib in Adult Patients With Metastatic Ocular MelanomaRadiochemotherapy Followed by Adjuvant Chemotherapy Based on Gemcitabine in Uterine Cervical CancerMetronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative CancerSentinel Lymph Node Technique in Multifocal Breast CancerPregnant Women With a Breast Cancer Diagnosed Between 2000 and 2014Effects of a Neuroscience-based Technique on Post-traumatic Stress Disorder Symptoms, Inflammation, and Survival in Cancer Patients Announced of a Palliative Disease Progression and Their PartnersTreatment Intensification With Temozolomide in Adults With a GlioblastomaCetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryVincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed RhabdomyosarcomaContinuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue SarcomaEndogenous Mechanisms of Inactivation of the Endothelium TumorFeasibility of Pet-scan at Day 1 of Brachytherapy for Patients With Cervical CancerFollow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast CancerPhase II Study of Regorafenib as Maintenance Therapy
P859
Q41696953-468E3772-679F-42C7-8D36-6EBD30EFED0AQ42383452-C0BE2636-9CAE-4F20-8122-1AE6439EB6C4Q42383461-0AE93107-B2C8-40FD-9304-58641BFE3786Q55536004-14EB0CD7-8BE4-47CE-9ED8-6D761B9C9261Q56381073-D0CAEE77-DF18-4669-AD10-E4A8580C8D79Q56742324-CD1D7419-08BB-4815-BCC2-1A8506D05245Q57006686-1AD9D610-C300-497C-A344-C03778AA74DCQ57078681-0E7A5B85-88FA-404A-BD5E-9907EDDFC3F8Q58128767-CFF24082-95F7-4DE9-92EB-B8E5F728C4CBQ60369258-7318A2E2-A397-444B-8106-C90A4379A500Q77057457-5FCAFB69-CCC4-42E7-9972-E123BE7077AEQ85679746-A67C9B87-4014-4FE1-816F-A4BCB3FB7E05Q86565941-9A107FD1-7A37-40D8-B119-EC698BB159A8
P108
Q58407098-3A1B7DE3-7A5E-41CF-99AA-8574DD015B53Q58407795-C49E4A21-1CA7-441F-861A-973F5588EA37Q58407870-EF00180E-2B86-4D0D-A377-59DD46BC78E6Q58845262-F7A79D8F-83AE-4EAC-89CB-0DAE95F12C2EQ58849116-63ECE5F4-EB60-4607-B840-9F6293F5D389Q58850054-EE3CF2FD-BD4F-4D80-858F-995E12F8AADAQ61862160-2FD7C310-AA78-4C85-8387-39D62CF407E7Q61894354-F757F5D3-7DA4-4660-800A-7801C2B50B09Q61906992-263613D1-8A94-47DC-807E-6F32CCC0C140Q61908980-862A491D-58F5-4616-8040-221C8D9D670CQ61915324-05AAB617-B679-4B03-A274-A379CD637968Q61921291-F5172781-017C-4E12-9116-B0564BB25F9BQ61921674-3B7EB986-6291-491D-9F13-4FCD41890FF7Q61921688-17B51B0F-30CA-4AA0-94F2-4452BB8A4FB2Q61921883-BDE271D9-2232-4A18-9445-BCC84CD0D1A9Q61921909-656D8414-6B96-415F-8A1F-74E5A3AE876AQ61921967-01CF5954-9096-46D0-9CA2-E1428A048A4EQ61922289-050CC605-A5FA-40EB-8130-5F8343F06D6AQ61923824-CA1E440A-96A3-4057-BFC2-646FE9C8CD43Q61924457-E96599C1-4162-424B-8FFC-1C31BBA9C239Q61933819-5A511737-E056-4913-BB59-AC84FD9C7A25Q61936616-B41C6629-AC7F-4A51-954C-2E7C0875F865Q61955790-7B2969ED-CAA9-4344-8DE4-AA12C7DE8BBFQ61956469-0AD75D94-9C09-4E77-9B68-76EA3C2C0B77Q61957444-8E1D941E-9279-4291-841E-ED5C6A09D115Q61969533-C4F8082B-8856-4075-9191-94954E8499E0Q61974983-7C877C27-9C20-4AEA-884E-628382E6BE1CQ61978988-E0B7D310-5CED-4EC2-BF20-1D146A78818DQ61980623-AF03F9DE-5D24-4DC9-8E03-4FD827CB6DA9Q61980670-3418DCD3-B6B4-418E-A691-AE9B8B6F318FQ61981439-14B6244E-3465-49B7-925E-C2DCAE659371Q62025255-396FDD64-9060-41A0-8059-E5993A0A50E8Q62025269-5F257C39-1BE0-4864-86CE-A1EFF608A2F7Q62025362-0C49D810-EC5F-4551-A7AF-55296E2D7C6EQ62030726-CC141B2C-5980-40D1-8294-44B24D7D20B1Q62031638-9F695E9B-00A5-44D3-A4FA-12CA07555C7DQ62034461-9890B326-B782-4ACF-B578-77DE7BB14D37Q62105028-CD154173-7E3F-4AA4-A044-9ABF9BB155C4Q62105033-20106AA0-7F22-4D60-8453-605F01C3DE4FQ62105842-8A080448-4927-45E0-B18D-3A61413E1A31
P6153
description
Centre régional de Lutte Contre le Cancer en Hauts de France
@fr
healthcare organization in Lille, France
@en
name
Centre Oscar Lambret
@en
Centre Oscar Lambret
@fr
type
label
Centre Oscar Lambret
@en
Centre Oscar Lambret
@fr
prefLabel
Centre Oscar Lambret
@en
Centre Oscar Lambret
@fr
P214
P268
P269
P131
P1616
P17
P213
0000 0001 0131 6312
P214
P2427
grid.452351.4
P268
P269
P3500
P4058
P625
Point (3.031934 50.613431)
P6782
P7859
viaf-140923784
P8062
Bbs0kjIxMTq6